Ivacaftor

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1295 publications

The role of real-world data and real-world evidence in advancing regulatory science and targeted therapeutics: a narrative review from the United States perspective.

The role of real-world data and real-world evidence in advancing regulatory science and targeted therapeutics: a narrative review from the United States perspective.

Journal: Personalized medicine

Published: April 04, 2026

Addressing the Release and Permeation Challenges of High-Tg Drugs in Amorphous Solid Dispersions.

Addressing the Release and Permeation Challenges of High-Tg Drugs in Amorphous Solid Dispersions.

Journal: Molecular pharmaceutics

Published: March 25, 2026

Comment on 'Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators'.

Comment on 'Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators'.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: March 13, 2026

Evolution of thoracic computed tomography after therapy with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis

Evolution of thoracic computed tomography after therapy with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis

Journal: Revue medicale de Liege

Published: March 12, 2026

Keeping up with CFTR modulator eligibility.

Keeping up with CFTR modulator eligibility.

Journal: Paediatric respiratory reviews

Published: March 10, 2026

Prenatal Elexacaftor/Tezacaftor/Ivacaftor for Fetal Meconium Ileus: First Italian Case and Narrative Overview of the Emerging Evidence.

Prenatal Elexacaftor/Tezacaftor/Ivacaftor for Fetal Meconium Ileus: First Italian Case and Narrative Overview of the Emerging Evidence.

Journal: Journal of clinical medicine

Published: February 19, 2026

Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis.

Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis.

Journal: Rhinology

Published: February 02, 2026

Single-cell profiling of BAL in preschool cystic fibrosis reveals macrophage dysregulation and ivacaftor-modified inflammatory programs in the early life lung.

Single-cell profiling of BAL in preschool cystic fibrosis reveals macrophage dysregulation and ivacaftor-modified inflammatory programs in the early life lung.

Journal: Mucosal immunology

Published: January 30, 2026

Chronic and acute modulator treatment restore wild-type-like activity and stability to the primary cystic fibrosis-causing CFTR variant.

Chronic and acute modulator treatment restore wild-type-like activity and stability to the primary cystic fibrosis-causing CFTR variant.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 23, 2026

Long-Term Adherence to Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis.

Long-Term Adherence to Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis.

Journal: Pulmonary therapy

Published: January 21, 2026

How do I treat : allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

How do I treat : allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

Journal: Revue medicale de Liege

Published: January 15, 2026

Restoration of Defective CFTR in Human Nasal Respiratory Epithelial Cells by CFTR Modulators and mRNA Transfection.

Restoration of Defective CFTR in Human Nasal Respiratory Epithelial Cells by CFTR Modulators and mRNA Transfection.

Journal: International journal of molecular sciences

Published: January 12, 2026

Showing 1-12 of 1,295

Last Updated: 04/28/2026